ReviewHealth science reports2025
A Systematic Review and Meta-Analysis of HIV/AIDS Prevalence Among Transgender Populations Worldwide.
Review in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- PrEP Use and Willingness Cascades Among Transgender Women in 11 Asian Countries: Findings From the PrEP APPEAL Cross-Sectional Online Survey.Journal of the International AIDS Society · 2026Article
- The HIV care continuum and determinants of antiretroviral therapy initiation among transgender women in France (1997-2023): a longitudinal cohort study.The Lancet regional health. Europe · 2026Article
- Prevalence of Reactive Rapid Test Results for Sexually Transmitted Infections and Associated Factors Among Transgender People Attending Specialized Health Services in Brazil.Infectious disease reports · 2026Article
- Sexual Behaviour, HIV Prevention and Testing Among Transgender and Non-binary People in a Cross-Sectional Behavioural Surveillance Survey in Aotearoa New Zealand.AIDS and behavior · 2026Article
- High Prevalence of and Low Testing for Sexually Transmitted Infections Among Transgender Women in Cali, Colombia.Sexually transmitted diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: The study's goal was to assess the global prevalence of HIV/AIDS infection in transgender people and to provide light on regional variances. Methods: A systematic search was conducted across multiple databases, including PubMed (Medline), Scopus, Web of Science, Embase, Ovid, and PsycINFO, from inception until September 2023. Studies were selected based on predefined inclusion and exclusion criteria, and quality was assessed using the Newcastle-Ottawa Scale (NOS). Heterogeneity was evaluated using Cochran's Results: The global prevalence of HIV/AIDS among transgender populations was 24% (CI: 12%-39%). Regional analysis revealed higher rates of HIV/AIDS among male-to-female (MTF) transgender individuals in Asia (30%, CI: 5%-54%) and Africa (35%, CI: 13%-57%) compared to other regions. In contrast, female-to-male (FTM) transgender individuals in Asia had a higher prevalence (23%, CI: 9%-31%) than those in the Americas (11%, CI: 3%-23%). Conclusion: Given the high prevalence of HIV/AIDS in the TG community worldwide and the significant variance within communities, it is critical to execute a comprehensive set of interventions to successfully prevent HIV/AIDS in transgender people.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.